Weight-loss giant Novo Nordisk's shares rose more than 5% to a high last hit in October, driven by ‘encouraging’ early US prescription data for its Wegovy pill, which the firm hopes will help it regain ground in the obesity drug race. #News #Reuters #Newsfeed #novonordisk #wegovy #wegovyweightloss Read the story here: https://reut.rs/4jSn55q 👉 Subscribe: http://smarturl.it/reuterssubscribe Keep up with the latest news from around the world: https://www.reuters.com/ Follow Reuters on Facebook:

Tag-uri: Facebook